This topic contains a solution. Click here to go to the answer

Author Question: In disproportionate stratified sampling, more data should be collected from the strata cells that a. ... (Read 78 times)

809779

  • Hero Member
  • *****
  • Posts: 579
In disproportionate stratified sampling, more data should be collected from the strata cells that
 a. are the most homogeneous c. have the smallest cell sizes
  b. are the most heterogeneous d. have the largest cell sizes

Question 2

The interquartile range is a measure of central tendency.
 
 Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kaykay69

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

B
More data should be collected from cells with the higher variability, i.e. the most heterogeneous.

Answer to Question 2

F
It is a measure of variability.




809779

  • Member
  • Posts: 579
Reply 2 on: Jun 29, 2018
Gracias!


kjohnson

  • Member
  • Posts: 330
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library